News tagged with hemophilia a
New animal model for hemophilia A developed
(PhysOrg.com) -- Researchers at Yale School of Medicine have developed a new animal model for studying hemophilia A, with the goal of eventually treating people with the disorder. Hemophilia A, a hereditary defect that prevents ...
Medicine & Health / Diseases, Conditions, Syndromes
Sep 03, 2010 |
not rated yet |
0
Search results for hemophilia a
U-M human embryonic stem cell line placed on national registry
The University of Michigan's first human embryonic stem cell line will be placed on the U.S. National Institutes of Health's registry, making the cells available for federally-funded research. It is the first of the stem ...
Feb 14, 2012 |
not rated yet |
0
Genes ex silico: Computer-designed virus yields phenotype expression benefits
(PhysOrg.com) -- Gene therapy is medicine’s rising star with adeno-associated virus (AAV) vectors – nonpathogenic parvoviruses – among the most promising supporting actors, due largely to their ...
Aug 29, 2011 |
4.8 / 5 (6) |
0
|
Genome editing, a next step in genetic therapy, corrects hemophilia in animals
Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice. This is the first time that genome ...
Jun 26, 2011 |
5 / 5 (6) |
2
|
Dilemmas of destiny: Genetic predictors of disease can raise thorny ethical issues
Lila (the patient’s name has been changed) was only in her 20s when she learned that she could be at increased risk for breast cancer. A genetic test had revealed that her mother carried a mutation signaling ...
Feb 28, 2011 |
not rated yet |
0
Scientist discovers natural molecule indirectly prevents stable clot formation
A scientist from The Scripps Research Institute has identified a new role for a natural signaling molecule in preventing blood clot formation. The molecule could become a target for the development of novel and cost-effective ...
Feb 01, 2011 |
not rated yet |
0
|
Why we need better drug monitoring
The use of recombinant activated factor 7 (rFVIIa) despite its potential for adverse events displays the serious shortcomings of Canada's current drug surveillance system, according to a commentary published in CMAJ (Canad ...
Medicine & Health / Medications
Jan 10, 2011 |
not rated yet |
0
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B
Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a vector under development at St. Jude Children's Research Hospital and UCL (University College ...
Medicine & Health / Medical research
Dec 06, 2010 |
not rated yet |
0
Hemostatic drug less effective than originally predicted
The use of recombinant activated factor 7 (rFVIIa) – a drug used to treat bleeding in hemophiliacs – in patients without hemophilia is not recommended because of the potential for adverse events, found a study published ...
Medicine & Health / Medications
Nov 15, 2010 |
not rated yet |
0
Medicine may be key to cloning's future
The cloning of animals may have come from agriculture, but its real promise may be in the lucrative field of medicine rather than as food.
Aug 17, 2010 |
5 / 5 (7) |
0
'Jumping genes' find new homes in humans more often than previously thought
Transposons, or "jumping genes," make up roughly half of the human genome. Geneticists previously estimated that they replicate and insert themselves into new locations roughly one in every 20 live births.
Jun 24, 2010 |
5 / 5 (5) |
0
List of search results for hemophilia a
